| Matrix metalloproteinase inhibitors and cancer—trials and tribulations LM Coussens, B Fingleton, LM Matrisian Science 295 (5564), 2387-2392, 2002 | 3469 | 2002 |
| Matrix metalloproteinases: biologic activity and clinical implications AR Nelson, B Fingleton, ML Rothenberg, LM Matrisian Journal of clinical oncology 18 (5), 1135-1135, 2000 | 2245 | 2000 |
| Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis L Yang, LM DeBusk, K Fukuda, B Fingleton, B Green-Jarvis, Y Shyr, ... Cancer cell 6 (4), 409-421, 2004 | 1371 | 2004 |
| Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1 V Noë, B Fingleton, K Jacobs, HC Crawford, S Vermeulen, W Steelant, ... Journal of cell science 114 (1), 111-118, 2001 | 940 | 2001 |
| The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors HC Crawford, BM Fingleton, LA Rudolph-Owen, KJH Goss, B Rubinfeld, ... Oncogene 18 (18), 2883-2891, 1999 | 934 | 1999 |
| The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoptosis WC Powell, B Fingleton, CL Wilson, M Boothby, LM Matrisian Current Biology 9 (24), 1441-1447, 1999 | 599 | 1999 |
| Matrix metalloproteinase-7–dependent release of tumor necrosis factor-α in a model of herniated disc resorption H Haro, HC Crawford, B Fingleton, K Shinomiya, DM Spengler, ... The Journal of clinical investigation 105 (2), 143-150, 2000 | 509 | 2000 |
| MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL CC Lynch, A Hikosaka, HB Acuff, MD Martin, N Kawai, RK Singh, ... Cancer cell 7 (5), 485-496, 2005 | 477 | 2005 |
| Moving targets: Emerging roles for MMPs in cancer progression and metastasis G Shay, CC Lynch, B Fingleton Matrix biology 44, 200-206, 2015 | 471 | 2015 |
| Matrix metalloproteinases: roles in cancer and metastasis B Fingleton Front Biosci 11 (1), 479-91, 2006 | 388 | 2006 |
| Abnormal TNF activity in Timp3−/− mice leads to chronic hepatic inflammation and failure of liver regeneration FF Mohammed, DS Smookler, SEM Taylor, B Fingleton, Z Kassiri, ... Nature genetics 36 (9), 969-977, 2004 | 351 | 2004 |
| MMPs as therapeutic targets—still a viable option? B Fingleton Seminars in cell & developmental biology 19 (1), 61-68, 2008 | 347 | 2008 |
| Matrix metalloproteinases as valid clinical target B Fingleton Current pharmaceutical design 13 (3), 333-346, 2007 | 328 | 2007 |
| Matrix metalloproteinases as regulators of inflammatory processes B Fingleton Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1864 (11), 2036-2042, 2017 | 280 | 2017 |
| Matrix metalloproteinase-3–dependent generation of a macrophage chemoattractant in a model of herniated disc resorption H Haro, HC Crawford, B Fingleton, JR MacDougall, K Shinomiya, ... The Journal of clinical investigation 105 (2), 133-141, 2000 | 243 | 2000 |
| Matrix metalloproteinase-9 from bone marrow–derived cells contributes to survival but not growth of tumor cells in the lung microenvironment HB Acuff, KJ Carter, B Fingleton, DL Gorden, LM Matrisian Cancer research 66 (1), 259-266, 2006 | 231 | 2006 |
| Epithelial NF-κB activation promotes urethane-induced lung carcinogenesis GT Stathopoulos, TP Sherrill, DS Cheng, RM Scoggins, W Han, ... Proceedings of the National Academy of Sciences 104 (47), 18514-18519, 2007 | 219 | 2007 |
| The PEA3 subfamily of Ets transcription factors synergizes with β-catenin–LEF-1 to activate matrilysin transcription in intestinal tumors HC Crawford, B Fingleton, MD Gustavson, N Kurpios, RA Wagenaar, ... Molecular and cellular biology 21 (4), 1370-1383, 2001 | 219 | 2001 |
| Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis B Fingleton, T Vargo-Gogola, HC Crawford, LM Matrisian Neoplasia 3 (6), 459-468, 2001 | 209 | 2001 |
| Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand T Vargo-Gogola, HC Crawford, B Fingleton, LM Matrisian Archives of biochemistry and biophysics 408 (2), 155-161, 2002 | 199 | 2002 |
